379 related articles for article (PubMed ID: 35364341)
1. Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America.
Quint JK; Arnetorp S; Kocks JWH; Kupczyk M; Nuevo J; Plaza V; Cabrera C; Raherison-Semjen C; Walker B; Penz E; Gilbert I; Lugogo NL; van der Valk RJP;
J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2297-2309.e10. PubMed ID: 35364341
[TBL] [Abstract][Full Text] [Related]
2. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
Hardy J; Baggott C; Fingleton J; Reddel HK; Hancox RJ; Harwood M; Corin A; Sparks J; Hall D; Sabbagh D; Mane S; Vohlidkova A; Martindale J; Williams M; Shirtcliffe P; Holliday M; Weatherall M; Beasley R;
Lancet; 2019 Sep; 394(10202):919-928. PubMed ID: 31451207
[TBL] [Abstract][Full Text] [Related]
3. The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today.
Krings JG; Beasley R
J Allergy Clin Immunol Pract; 2024 Apr; 12(4):870-879. PubMed ID: 38237858
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.
Beasley R; Harrison T; Peterson S; Gustafson P; Hamblin A; Bengtsson T; Fagerås M
JAMA Netw Open; 2022 Mar; 5(3):e220615. PubMed ID: 35230437
[TBL] [Abstract][Full Text] [Related]
5. Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines.
Lin J; Zhou X; Wang C; Liu C; Cai S; Huang M
Expert Rev Respir Med; 2018 Mar; 12(3):191-202. PubMed ID: 29400090
[TBL] [Abstract][Full Text] [Related]
6. The management of mild asthma.
O'Byrne PM; Reddel HK; Beasley R
Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33093120
[TBL] [Abstract][Full Text] [Related]
7. Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programme.
Bao W; Zhang Y; Hang J; Guo Y; Tang W; Yun C; Deng J; Jin M; Lai K; Yu H; Beekman M; Zhou X; Zhang M
Ther Adv Respir Dis; 2022; 16():17534666221115054. PubMed ID: 36065527
[TBL] [Abstract][Full Text] [Related]
8. The Myth of Mild: Severe Exacerbations in Mild Asthma: An Underappreciated, but Preventable Problem.
Kaplan A
Adv Ther; 2021 Mar; 38(3):1369-1381. PubMed ID: 33474708
[TBL] [Abstract][Full Text] [Related]
9. Short-acting β
Theerakittikul T; Nakwan N; Niyompattama A; Siriphan P; Beekman MJHI
J Asthma; 2023 Dec; 60(12):2177-2188. PubMed ID: 37405933
[TBL] [Abstract][Full Text] [Related]
10. Short-acting β
Yorgancıoğlu A; Aksu K; Naycı SA; Ediger D; Mungan D; Gül U; Beekman MJHI;
BMC Pulm Med; 2022 Jun; 22(1):216. PubMed ID: 35655251
[TBL] [Abstract][Full Text] [Related]
11. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
12. Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma.
Beasley R; Harper J; Bird G; Dunphy H; Semprini A; Pavord ID; Papi A; Weatherall M
BMC Pulm Med; 2019 Dec; 19(1):264. PubMed ID: 31883519
[TBL] [Abstract][Full Text] [Related]
13. Over-prescription of short-acting β
Chakaya J; Mecha J; Beekman M
BMC Prim Care; 2023 Jul; 24(1):141. PubMed ID: 37422638
[TBL] [Abstract][Full Text] [Related]
14. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
Reddel HK; Bacharier LB; Bateman ED; Brightling CE; Brusselle GG; Buhl R; Cruz AA; Duijts L; Drazen JM; FitzGerald JM; Fleming LJ; Inoue H; Ko FW; Krishnan JA; Levy ML; Lin J; Mortimer K; Pitrez PM; Sheikh A; Yorgancioglu AA; Boulet LP
J Allergy Clin Immunol Pract; 2022 Jan; 10(1S):S1-S18. PubMed ID: 34718211
[TBL] [Abstract][Full Text] [Related]
15. The use of short-acting bronchodilators and cost burden of asthma across Global Initiative for Asthma-based severity levels: Insights from a large US commercial and managed Medicaid population.
Pollack M; Gandhi H; Tkacz J; Lanz M; Lugogo N; Gilbert I
J Manag Care Spec Pharm; 2022 Aug; 28(8):881-891. PubMed ID: 35708342
[No Abstract] [Full Text] [Related]
16. As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?
Domingo C; Rello J; Sogo A
Drugs; 2019 Nov; 79(16):1729-1737. PubMed ID: 31584145
[TBL] [Abstract][Full Text] [Related]
17. Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials.
Hatter L; Houghton C; Bruce P; Holliday M; Eathorne A; Pavord I; Reddel HK; Hancox RJ; Braithwaite I; Oldfield K; Papi A; Weatherall M; Beasley R;
BMJ Open Respir Res; 2022 Aug; 9(1):. PubMed ID: 36007980
[TBL] [Abstract][Full Text] [Related]
18. It is time to change the way we manage mild asthma: an update in GINA 2019.
Muneswarao J; Hassali MA; Ibrahim B; Saini B; Ali IAH; Verma AK
Respir Res; 2019 Aug; 20(1):183. PubMed ID: 31412856
[TBL] [Abstract][Full Text] [Related]
19. Clinical standards for the diagnosis and management of asthma in low- and middle-income countries.
Jayasooriya S; Stolbrink M; Khoo EM; Sunte IT; Awuru JI; Cohen M; Lam DC; Spanevello A; Visca D; Centis R; Migliori GB; Ayuk AC; Buendia JA; Awokola BI; Del-Rio-Navarro BE; Muteti-Fana S; Lao-Araya M; Chiarella P; Badellino H; Somwe SW; Anand MP; Garcí-Corzo JR; Bekele A; Soto-Martinez ME; Ngahane BHM; Florin M; Voyi K; Tabbah K; Bakki B; Alexander A; Garba BL; Salvador EM; Fischer GB; Falade AG; ŽivkoviĆ Z; Romero-Tapia SJ; Erhabor GE; Zar H; Gemicioglu B; Brandão HV; Kurhasani X; El-Sharif N; Singh V; Ranasinghe JC; Kudagammana ST; Masjedi MR; Velásquez JN; Jain A; Cherrez-Ojeda I; Valdeavellano LFM; Gómez RM; Mesonjesi E; Morfin-Maciel BM; Ndikum AE; Mukiibi GB; Reddy BK; Yusuf O; Taright-Mahi S; Mérida-Palacio JV; Kabra SK; Nkhama E; Filho NR; Zhjegi VB; Mortimer K; Rylance S; Masekela RR
Int J Tuberc Lung Dis; 2023 Sep; 27(9):658-667. PubMed ID: 37608484
[TBL] [Abstract][Full Text] [Related]
20. Asthma-Related Health Outcomes Associated with Short-Acting β
Bloom CI; Cabrera C; Arnetorp S; Coulton K; Nan C; van der Valk RJP; Quint JK
Adv Ther; 2020 Oct; 37(10):4190-4208. PubMed ID: 32720299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
